Navigation Links
Brazilian, Russian, Indian and Chinese Markets For Electrophysiology Mapping and Ablation Devices Will See Rapid Growth Through 2022
Date:10/2/2013

edure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Brazilian, Indian and Chinese Orthopedic Markets to See Strong Growth Through 2017
2. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
3. Lilly Statement on Indiana Biosciences Research Institute
4. Contract Manufacturer RMI hosts Central Indiana Jobs Roundtable with U.S. Senator Joe Donnelly
5. CHPA Statement on Statewide Indiana Consumer Poll
6. 50 Indian Companies to Collectively Invest $500 Million in US Market
7. The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
8. Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment
9. Eminent Members of Global and Indian Community to Celebrate Rolex Awards at Gala New Delhi Ceremony
10. Lilly to Expand Indianapolis Insulin Manufacturing Operations
11. Henry Schein Chairman and CEO Stanley M. Bergman Honored By Hispanic Dental Association, National Dental Association and Society of American Indian Dentists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
(Date:7/30/2014)... and PARIS , July 30, 2014 ... and Sanofi (EURONEXT: SAN and NYSE: SNY ... trials of alirocumab in people with hypercholesterolemia met their ... baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks ... investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ...
(Date:7/30/2014)... , July 30, 2014  DigiPath, Inc. (OTCBB ... is expanding into the cannabis testing and education markets, ... its business and affairs not previously disclosed or, to ... recent unusual market action. "We have noticed ... the last three trading days," said Steve Barbee ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... Jan. 5, 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 study with ISIS-TTRRx.  The results demonstrated ... reductions of greater than 80 percent in transthyretin ... well tolerated with no significant adverse events.  ISIS-TTRRx ...
... (NASDAQ: AMRI ), a global contract services ... preferred provider agreement with BioPontis Alliance LLC. The agreement ... gap between early-stage research and technologies being discovered and ... provide its services in small molecule discovery, development, and ...
Cached Medicine Technology:ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 2ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 3ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 4AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
(Date:7/30/2014)... Vail and Beaver Creek, Colo., skiers have probably ... Skier.” Those skiers and guides are enjoying time on ... a non-profit organization founded in 2001 that matches volunteer ... snow sport opportunities. Visually impaired skiers and snowboarders and ... up an application to participate in the program at ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
(Date:7/30/2014)... with severe combined immunodeficiency (SCID) can be successfully treated ... experts led by Memorial Sloan Kettering,s Richard J. O,Reilly, ... protocols. Their review will be published in the July ... Medicine . , SCID is a group of inherited ... When this breakdown occurs, babies no longer have the ...
(Date:7/30/2014)... The Restore My Blood Sugar review recently published by ... can now find an amazingly successful method of reducing stress ... by D. Chao and Andrew Forester who claim that certain ... comes to normalizing blood sugar levels. Chao actually is a ... the cure of diabetes that all patients should find out ...
(Date:7/30/2014)... Bentonville, AR (PRWEB) July 30, 2014 ... providing their patients with free oral cancer screenings. Using ... team will work to detect the disease in its ... the lips, tongue, cheek, mouth, sinuses, throat and other ... National Cancer Institute’s Surveillance, Epidemiology, and Ends Results (SEER) ...
Breaking Medicine News(10 mins):Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2
... in South India wake up to the lovely smell of ... these coffee lovers now, with firm evidence from recent research. ... jolt and has been found to contain substances called as ... general have been linked to a number of potential health ...
... containing sugar, added caffeine and guarana causes the body to ... lemonade. // Lemonade and other sodas are already being ... obesity as many have a high sugar content. ... 18 to 22 from a range of ethnicities. The subjects ...
... diagnosed in men and the risk of developing this ... form of therapy for prostate cancer remains still a ... available to patients: traditional open surgery, laparoscopic (also known ... ,Prostate cancer patients biggest concerns following these treatment ...
... New Haven, Conn. – Ever since the treatment methodologies to treat ... the difference in survival between male and female patients, whites and ... one of the largest national studies on this topic in the ... recommended treatments’ - such as aspirin, beta-blockers and reperfusion ...
... Older women who try to lose weight apparently have to ... on weight loss , the supermodel Rachel Hunter has criticized ... weight loss. , ,Hunter said that Hatcher's face looked ... who was once married to rocker Rod Stewart, went on ...
... the northern sections of Uttar Pradesh. The officials have ... reports from health officials. , ,On Saturday the medical ... "is bound to be much higher" as many deaths may ... 900 patients have been admitted to different government hospitals and ...
Cached Medicine News:Health News:Benefits Of Robotic Prostate Surgery- But At What Cost? 2Health News:Women and Black Patients have less chances to survive a Heart Attack 2Health News:Hollywood Actress Hunter criticises Hatcher for weight loss. 2
... Lubri-Flex Open Tip Ureteral Stents combine ... body temperature while remembering its shape with ... ultra-slippery when moistened. The result is a ... of placement and patient comfort. Lubri-Flex® is ...
... The Pathfinder Chlamydia Culture ... reliable staining of intracellular ... reticulate bodies) in tissue ... antibody used in this ...
... Pathfinder RSV EIA Kit is a direct antigen ... aspirates. It uses polyclonal and monoclonal antibodies ... This assay combines the specificity and reproducibility of ... an EIA. Qualitative results are availalbe within ...
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
Medicine Products: